Recent Company News

• 06:52 AM ET Aug 06, 2026
  

  Media, telecom, banks, energy and utilities outperform; industrials, travel and tech the main laggards:

• 04:14 AM ET Aug 06, 2026
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 02:58 AM ET Aug 06, 2026
  

  StreetAccount Metrics Recap - Hikma Pharmaceuticals H1 Earnings (1571.0000p, 0)

• 02:05 AM ET Aug 06, 2026
  

  Hikma Pharmaceuticals reports H1 Core EPS $1.28 vs consensus $1.12; confirms FY guidance (1571.0000p, 0)

• 05:59 AM ET Aug 05, 2026
  

  StreetAccount Consensus Metrics Preview - Hikma Pharmaceuticals H1 Earnings (15.9000p, +0.09)

• 02:53 AM ET Jul 22, 2026
  

  StreetAccount Summary - European pre-market trading update

• 07:08 PM ET Jul 21, 2026
  

  President Trump states tariff on generic drugs will stay at 0% for 2 years then rise to 100% - Truth Social

• 07:26 AM ET Jul 21, 2026
  

  Shanghai Junshi Biosciences' new indication application for JS001 accepted by NMPA (HK$19.59, 0.00)

• 06:18 PM ET Jul 16, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 02:21 AM ET Jul 16, 2026
  

  Hikma Pharmaceuticals initiated buy at Citi (1495.0000p, 0)